SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is currently gaining momentum as a community-driven project that emphasizes cultural identity and long-term engagement ahead of the 4/20 period. The project is actively building a supportive ecosystem, with participants highlighting its unique position in the cannabis-themed crypto space and discussing its long-term growth potential.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is currently trending due to intense community discussion surrounding its high short interest and speculative potential for a gamma squeeze, fueled by a heavy volume of call options expiring in mid-April. Investors are actively debating the leadership of CEO John Jacobs and the potential for activist investor Himanshu Shah to initiate a proxy fight, as sentiment remains polarized between those anticipating a major partnership or buyout and those frustrated by persistent share price suppression.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently trending due to a convergence of bullish sentiment surrounding its post-quantum cryptography capabilities and its potential role in real-world asset tokenization. Community members are actively debating the impact of recent institutional developments and governance changes, with many highlighting the project's long-term utility as a primary driver for its potential market recovery.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is surging following a massive $2 billion strategic investment from Nvidia, which ties the company directly into the NVLink Fusion ecosystem and cements its role as a critical architect for next-generation AI data centers. Investors are heavily focused on the company's robust custom silicon and optical interconnect capabilities, fueling intense institutional activity and bullish sentiment as the stock breaks out of recent consolidation.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as investors highlight its role as critical DeFi infrastructure, bolstered by a high-profile partnership with the U.S. Department of Commerce to provide on-chain macroeconomic data. The community is actively discussing the project's institutional adoption, its revenue-generating model featuring token buybacks, and its positioning as a leading player in the expanding Real World Asset (RWA) sector.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire Corp is experiencing significant volatility driven by a mix of new contract wins with the European Space Agency and ongoing investor concerns regarding insider selling from private equity holders. The community remains divided, with some traders focused on short-term technical resistance near the $10 level, while others are bullish on the company's long-term integration into defense and national security supply chains.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is seeing intense community debate as market volatility fuels speculation about its long-term viability versus its potential as a core blockchain rail. While some traders are focused on short-term technical patterns and dip-buying opportunities, broader sentiment is fractured by concerns over network reliability and the impact of recent decentralized exchange exploits on investor confidence.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is drawing significant investor interest as the market closely monitors the company's progress toward a highly anticipated FDA submission for ivonescimab, with many anticipating a major catalyst in the coming year. While technical analysts are highlighting the potential for a short squeeze driven by high short interest and a limited float, long-term investors are focused on the broader clinical pipeline and the potential for the therapy to reshape the non-small cell lung cancer treatment landscape.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending due to strong fourth-quarter financial results that beat revenue estimates and highlighted significant year-over-year growth. Community discussion is focused on the company's expanding customer base, the strategic scaling of silicon anode battery production for defense and drone applications, and anticipation regarding future contract announcements.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing high volatility and significant momentum as investors digest recent large-scale orders from hyperscale customers, fueling aggressive debates between bulls targeting major growth and bears citing potential overvaluation and dilution risks. The community remains hyper-focused on its role in the data center and AI infrastructure supercycle, frequently comparing its price action to sector peers like Lumentum and Coherent while monitoring the impact of high short interest and institutional influence on the stock's rapid swings.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can These 3 ETF Losers of 2025 Rebound in 2026?

Can beaten-down cloud ETFs like WCLD, staples ETF FXG, and India ETFs INCO & INQQ stage a rebound in 2026 after a mixed 2025?

The Geopolitical Windfall for Indian ETFs as Trump Hints at Tariff Cut 

Indian ETFs like INDA and FLIN gain spotlight as U.S.-India trade deal seems to near, which could slash tariffs and reignite investor confidence. 

Decent Growth Vs. Tariff Fears: What Lies Ahead of India ETFs?

India's economy grew at an annual rate of 7.8% in the quarter ending June, topping economists' expectations of 6.7% (Reuters poll), as quoted on CNBC.

Shares of MakeMyTrip ($MMYT) jumped 6% on Thursday as the online travel company reported strong revenue jump for its third-quarter earnings compared to last year but missed earnings estimates, with retail sentiment staying bearish.MakeMyTrip posted diluted earnings per share of $0.23, below the consensus estimate that Wall Street analysts expected at $0.27, according to Stocktwits data.&nbsp;However, Its revenues stood at $267.4 million, jumping 24.8% year-over-year, beating consensus estimates of $268.1 million.The increase in revenue was primarily due to strong travel demand in India for both domestic and international outbound travel in the quarter, the company said. The revenue increase was led by its hotels and packages business which saw an increase of 23.4% over the last quarter to $121.9 million.As at December 31, the company's cash and cash equivalents and term deposits stood at $705.5 million.“The Indian travel and tourism sector is witnessing robust growth, reflecting a strong desire among travelers to explore new horizons. While Indian destinations continue to shine, many countries have made significant efforts to attract Indian travelers. Our strong performance this quarter reflects these macro trends, along with our focused execution and commitment to customer centricity," Rajesh Magow, Group CEO said.Sentiment on Stocktwits inched up to 'bearish' from 'extremely bearish.' Message volumes were in the 'high' zone compared to 'extremely high' a day ago.<figure class="image"><img style="aspect-ratio:1292/308;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_01_24_at_8_49_50_AM_778ce36030.png" alt="Screenshot 2025-01-24 at 8.49.50 AM.png" width="1292" height="308"><figcaption>MakeMyTrip sentiment meter and message volumes on Jan 23 as of 10:40 pm ET</figcaption></figure>To be sure, some commenters on the Stocktwits platform were still bullish.<stembedurl>https://stocktwits.com/NotaTraitor/message/601144059</stembedurl>MakeMyTrip offers air ticketing, hotels and packages, and rail tickets, among other ancillary travel services. &nbsp;MakeMyTrip stock is down 2.53% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com

Representative image. Source: Getty Images

MakeMyTrip Stock Surges After Q3 Revenue Jump: Retail's Not Convinced

Its revenues stood at $267.4 million, jumping 24.8% year-over-year, beating consensus estimates

Equity

Shares of MakeMyTrip ($MMYT) have fallen about 2% in the past five days ahead of the online travel company’s third-quarter earnings, dampening retail sentiment.MakeMyTrip will report its financial and operating results before the bell on Thursday, January 23.Wall Street analysts expect $0.27 in earnings per share on estimated revenues of $264.99 million, according to Stocktwits data. The full year 2025's EPS is expected to be about $1.04 per share on revenue of $989.86 million.For the second quarter, MakeMyTrip reported $210.99 million in revenues, missing analyst expectations. Its EPS stood at $0.16, also falling short of estimates of $0.18.Sentiment on Stocktwits was in the ‘extremely bearish’ zone compared to last week. Message volumes have increased to ‘extremely high’ from ‘high.’ <img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_01_23_at_7_03_01_AM_e22d3a31b6.png" alt="Screenshot 2025-01-23 at 7.03.01 AM.png"> However, BofA analyst Sachin Salgaonkar took a more positive view on the stock, raising the firm's price target to $130 from $119 with a ‘Buy’ rating, Fly.com reported.According to the analyst, normal strong seasonality trends have been in play in the third quarter for the industry and MakeMyTrip is expected to report "a strong set of numbers in the seasonally strong" quarter, added the report.MakeMyTrip offers air ticketing, hotels and packages, and rail tickets, among other ancillary travel services. &nbsp;MakeMyTrip stock is down 8% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com

MakeMyTrip Stock In Focus Ahead of Q3 Earnings: Retail’s Downbeat

Sentiment on Stocktwits was in the ‘extremely bearish’ zone compared to last week.

Shares of MakeMyTrip ($MMYT) were in the spotlight on Friday morning after the company received a price target revision from Bofa Securities on the back of growing travel demand. However, retail sentiment remained ‘neutral.’Bofa analyst Sachin Salgaonkar raised the price target for MakeMyTrip from $119.00 to $130.00 with a ‘Buy’ rating, The Fly.com reported. The analyst reportedly has a positive outlook on the company's earnings potential and market position in the travel industry. Specifically, the roll forward of the company's discounted cash flow (DCF) analysis prompted the hike, Investing.com <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.investing.com/news/analyst-ratings/bofa-maintains-buy-on-makemytrip-stock-despite-minor-eps-impact-from-inr-weakness-93CH-3789828">reported.</a>The company’s recent $150 million share buyback program also serves as a safety net for the stock price and offers support to the company’s market valuation.MakeMyTrip stock has risen 2.32% in the past five days and is up 153% year-to-date.Retail sentiment on Stocktwits was ‘neutral’ with message volumes leaning high, showing increased investor attention on the stock.<figure class="image"><img style="aspect-ratio:1256/302;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_27_at_7_27_37_PM_8c1788e1d5.png" alt="Screenshot 2024-12-27 at 7.27.37 PM.png" width="1256" height="302"><figcaption>MMYT sentiment meter and message volumes on Dec 27th as of 9:15 am ET</figcaption></figure>Several commenters on Stocktwits, however, were bullish on the overall prospects for travel stocks.<stembedurl>https://stocktwits.com/MaverikIT/message/597866494</stembedurl><stembedurl>https://stocktwits.com/MaverikIT/message/597653965</stembedurl><stembedurl>https://stocktwits.com/AskLou/message/597468745</stembedurl>MakeMyTrip offers air ticketing, hotels and packages, and rail tickets, among other ancillary travel services. &nbsp;The company is expected to report third-quarter earnings in January. Wall Street analysts expect $0.27 in earnings per share on estimated revenues of $264.99 million.For updates and corrections, email newsroom[at]stocktwits[dot]com.

MakeMyTrip Stock In Spotlight After BofA’s Price Target Revision: But Retail's Neutral

MakeMyTrip stock has risen 2.32% in the past five days.

Exchange Traded Concepts Trust - INQQ The India Internet ETF

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Current Price	$11.71
Prev Close	$11.73
Open	$11.66
Dividend Yield	N/A
50-Day Moving Average	$12.84
Beta	N/A
Avg. Volume	31,105.17
PE Ratio	N/A

52-Week High	$16.67
52-Week Low	$11.25
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

INQQ
Exchange Traded Concepts Trust - India Internet & Ecommerce ETF

Feed

News

Sentiment

Fundamentals

Info

Latest INQQ News

INQQExchange Traded Concepts Trust - India Internet & Ecommerce ETF